Maravai Lifesciences Holdings (MRVI) Asset Utilization Ratio (2021 - 2026)

Maravai Lifesciences Holdings' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.28 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 12.27% year-over-year to 0.28; the TTM figure through Mar 2026 stood at 0.28 (up 12.27% YoY), while the FY2025 annual figure was 0.21, up 0.55% from the prior year.
• Asset Utilization Ratio was 0.28 for Q1 2026 at Maravai Lifesciences Holdings, up from 0.23 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.45 in Q1 2022 to a low of 0.15 in Q4 2023.
• Historically, Asset Utilization Ratio has averaged 0.27 across 5 years, with a median of 0.24 in 2025.
• The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio surged 55.43% in 2022, then slumped 60.51% in 2023.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.39 in 2022, then tumbled by 60.51% to 0.15 in 2023, then jumped by 47.31% to 0.23 in 2024, then gained by 1.16% to 0.23 in 2025, then rose by 20.32% to 0.28 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.28 (Q1 2026), 0.23 (Q4 2025), and 0.22 (Q3 2025), per Business Quant data.